Is NanoBio heading towards an IPO?
Probably way too early to make that call. But the Ann Arbor, MI-based drug startup and its investors are not exactly discouraging such talk.
“I think the company has the potential to be a public company,” says George Arida, a managing director of Venture Investors. “It absolutely has the breadth [of potential products] to do that. It’s not too far down the road to go down the path towards an IPO.”